Delivery Order SPE2DB20D1050-SPE2DB24FH32J
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,039.26, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen (2 ml), a specialty pharmaceutical product. The contract has a ceiling value of $5,671.17 and a period of performance running through March 31, 2025. It is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,240.34, is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a prescription medication, with a ceiling value of $9,366.30. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 12, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a prescription medication. The fixed-price delivery order has a ceiling value of $27,344.64 and a completion date of June 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $14,538.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a period of performance through April 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication, with a ceiling value of $10,288.57 and a completion date of January 31, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,869.37, is for the delivery of Dupixent 300 mg/2 ml Pen 2 ml, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of February 3, 2025. This award does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,619.72, is a delivery order for Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has an ultimate completion date of July 29, 2024 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award, valued at $13,675.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH32JDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen (2 ml), a specialty pharmaceutical product. The award has a ceiling value of $13,393.79 and an ultimate completion date of October 18, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 10/17/23 |